Recurrent pleural effusion in patient with liver cirrhosis – a case report

  • Diah Pradnya Paramita Department of Internal Medicine, Wangaya Regional Hospital, Denpasar, Bali
    pradnyadiah@yahoo.com
  • Putu Indri Widiani Department of Internal Medicine, Wangaya Regional Hospital, Denpasar, Bali
  • I Wayan Sunaka Department of Internal Medicine, Wangaya Regional Hospital, Denpasar, Bali

Abstract

Liver cirrhosis is caused by necrosis of liver cells leading to fibrosis and nodule formation. Structural abnormalities of the liver causing impaired hepatocyte function and portal hypertension. Hepatic hydrothorax is a less common pulmonary complication of portal hypertension. We present a 47 years old man with liver cirrhosis and recurrent massive pleural effusion. Diagnosis can be challenging because it can be associated with pulmonary or systemic disorders. Pleural fluid analysis is necessary to differentiate transudate or exudate as the cause of pleural effusion. Thoracentesis is done to reduce the complaints experienced by the patient.

Keywords: Liver cirrhosis, Pleural effusion, Hepatic hydrothorax

Downloads

Download data is not yet available.

References

1. Suva M. Review article A Brief Review on Liver Cirrhosis : Epidemiology, Etiology, Pathophysiology, Symptoms, Diagnosis and Its Management. Mol Pharmacol. 2014;(2):1–5.
2. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. Hepatology. 2019;70(1):151–71.
3. Sharma B, John S. Hepatic Cirrhosis. StatPearls Publishing LLC; 2020.
4. Krok KL, Cardenas A. Hepatic hydrothorax. Semin Respir Crit Care Med. 33(1):3–10.
5. José M P. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med. 20(4):352–7.
6. Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatology; 2017;11(4):317–70.
7. Chedid MF, Kruel CRP, Pinto M a, Grezzana-Filho TJM, Leipnitz I, Kruel CDP, et al. Review Article Hepatocellular Carcinoma: Diagnosis and Operative Management. Arqu Brasi Cir Dig. 2017;30(4):272–8.
8. Roussos A, Philippou N, Mantzaris GJ, Gourgouliannis KI. Hepatic hydrothorax: Pathophysiology diagnosis and management. J Gastroenterol Hepatol. 2007;22(9):1388–93.
9. Huang PM, Chang YL, Yang CY, Lee YC. The morphology of diaphragmatic defects in hepatic hydrothorax: Thoracoscopic finding. J Thorac Cardiovasc Surg. 2005;130(1):141–5.
10. Lv Y, Han G, Fan D. Hepatic hydrothorax. Ann Hepatol. Elsevier; 2018;17(1):33–46.
11. Karkhanis VS, Joshi JM. Pleural effusion: Diagnosis, treatment, and management. Open Access Emerg Med. 2012;4:31–52.
12. Mercer RM, Corcoran JP, Porcel JM, Rahman NM, Psallidas I. Interpreting pleural fluid results. Clin Med J R Coll Physicians London. 2019;19(3):213–7.
13. Singh A, Bajwa A, Shujaat A. Evidence-based review of the management of hepatic hydrothorax. Respiration. 2013;86(2):155–73.
14. C SS. Reexpansion pulmonary edema: a case report and review of the current literature. Journal of Emergency Medicine. 2003;24(1):23:7.
15. Kopman DF, Berkowitz D, Boiselle P, Ernst A. Large-volume thoracentesis and the risk of reexpansion pulmonary edema.. 2007;84(5):61.
16. Hung T-H, Tseng C-W, Tsai C-C, Tseng K-C, Hsieh Y-H. The long-term outcomes of cirrhotic patients with pleural effusion. Saudi Journal Gastroenterol . 2018;24((1)):46–51.
Published
31-08-2021
Statistics
59 Views | 15 Downloads
Citatons
How to Cite
Paramita, D. P., Putu Indri Widiani, and I Wayan Sunaka. “Recurrent Pleural Effusion in Patient With Liver Cirrhosis – a Case Report”. World Journal of Current Medical and Pharmaceutical Research, Vol. 3, no. 4, Aug. 2021, pp. 101-3, doi:10.37022/wjcmpr.v3i4.186.
Section
Case Reports